Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ainhoa, Ruiz Del Agua"'
Publikováno v:
Therapeutic Drug Monitoring.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59e236f7b13648bf55540c89110ea55f
https://doi.org/10.1097/ftd.0000000000001095
https://doi.org/10.1097/ftd.0000000000001095
Autor:
Antonio Escobar, Juan Ramon De Dios, I. Gorostiza, Ainhoa Ruiz del Agua, J. Belzunegui, Ziortza Trancho, Ana Ruibal-Escribano, Lorena del Rio, Cristina Jorquera, Margarida Vasques, Eduardo Úcar, Antonio Pérez Martínez, Clara Pérez, Catalina Gomez-Arango, Eli Diez, C. Stoye, Belen Alvarez, Daniel Nagore, Maria Luz García-Vivar
Publikováno v:
Rheumatology and Therapy
Introduction To assess the clinical and cost-effectiveness of therapeutic drug monitoring (TDM) based on serum adalimumab levels compared to standard of care in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7679549b9145169ab5db6de9eb0f104b
https://pubmed.ncbi.nlm.nih.gov/34278555
https://pubmed.ncbi.nlm.nih.gov/34278555
Autor:
Rosa Izu-Belloso, Ainhoa Ruiz del Agua, Daniel Nagore, Jaime González del Tánago, Peru Urigoitia-Ugalde, Antonio Martínez, Sergio Martín-González, Jesús Careaga, Rosaura Navarro, Laura Blanch
Publikováno v:
Journal of the American Academy of Dermatology. 80:1782-1784
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f885e8caa2781c1fb0c57b91ee832760
https://doi.org/10.1016/j.jaad.2018.12.021
https://doi.org/10.1016/j.jaad.2018.12.021
Autor:
Ana, Martínez-Feito, Chamaida, Plasencia-Rodriguez, Victoria, Navarro-Compán, Teresa, Jurado, Eva Linda, Kneepkens, Gertjan J, Wolbink, Sergio, Martín, Ainhoa, Ruiz Del Agua, Rosaura, Navarro, Araceli, Mezcua, Andrea, Jochems, Diana, Peiteado, Maria Gema, Bonilla, Alejandro, Balsa, Dora, Pascual-Salcedo
Publikováno v:
Clinical and experimental rheumatology. 36(1)
Objective To investigate the association between serum golimumab (GLM) trough levels, clinical disease activity and treatment response during the first year of therapy in patients with axial spondyloarthritis (axSpA), as well as determining an optima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::54dd1b20f123539cb56a375edc228113
https://pubmed.ncbi.nlm.nih.gov/28980904
https://pubmed.ncbi.nlm.nih.gov/28980904
Autor:
Dora Pascual-Salcedo, Ainhoa Ruiz del Agua, Daniel Nagore, Jesús Díez, Laura Nuño, Emilio Martín-Mola, Diana Peiteado, Alejandro Villalba, Gema Bonilla, Rosario Moral, Chamaida Plasencia, Alejandro Balsa
Publikováno v:
Annals of the Rheumatic Diseases. 71:1955-1960
Infliximab (IFX) is a monoclonal antibody against tumour necrosis factor α that is effective for treating spondyloarthritis (SpA). However, after initial success of the drug some patients lose responsiveness or develop infusion reactions, which may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d972fb108693b6df3f110d4082f78d31
https://doi.org/10.1136/annrheumdis-2011-200828
https://doi.org/10.1136/annrheumdis-2011-200828
Autor:
Ainhoa Ruiz del Agua, Emilio Martín-Mola, Daniel Nagore, Dora Pascual-Salcedo, Laura Nuño, Lucien Aarden, Antonio Martínez, Gema Bonilla, S. Ramiro, Chamaida Plasencia, Alejandro Balsa
Publikováno v:
Rheumatology. 50:1445-1452
Objective. To analyse the clinical relevance of the production of anti-infliximab antibodies (anti-infliximab Abs) in patients with RA undergoing infliximab treatment over a prolonged period of time. Methods. Clinical characteristics, serum trough in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8886bcce29d6b09ed9c3c483cb919810
https://doi.org/10.1093/rheumatology/ker124
https://doi.org/10.1093/rheumatology/ker124
Autor:
Ainhoa Ruiz del Agua, Alberto Monasterio, Daniel Nagore, Antonio Martínez, N. Torres, Begoña Ruiz-Argüello
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 51:e287-e289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add2971976eafef3001dca9d7787f10f
https://doi.org/10.1515/cclm-2013-0461
https://doi.org/10.1515/cclm-2013-0461
Autor:
Daniel Nagore, Dora Pascual-Salcedo, Ainhoa Ruiz del Agua, Rosaura Navarro, S. Martin, Antonio Martínez, Chamaida Plasencia, N. Torres, Begoña Ruiz-Argüello
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d868cd62595f66efd2cff7174de6380e
https://doi.org/10.1515/cclm-2015-0266
https://doi.org/10.1515/cclm-2015-0266
Autor:
M. Begoña Ruiz-Larrea, Roberto Matorras, Igor Aurrekoetxea, Rosaura Navarro, Begoña Prieto, José Ignacio Ruiz-Sanz, Ainhoa Ruiz del Agua, M. Luisa Hernández
Publikováno v:
Fertility and sterility. 94(4)
Objective To evaluate the serum oxidizability and antioxidant status in women undergoing an in vitro fertilization (IVF) cycle and to assess the possible relationship of the oxidizability indexes with the pregnancy rate. Design Prospective, longitudi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6826c552f7dd6375bc40364639d1a7
https://pubmed.ncbi.nlm.nih.gov/19540482
https://pubmed.ncbi.nlm.nih.gov/19540482
Autor:
J. Pascual, Daniel Nagore, Ainhoa Ruiz del Agua, Belen Herreros, Francisca Llinares-Tello, Antonio Martínez
Publikováno v:
Gastroenterology. 148:S-860
Introduction Anti-TNF antibody, infliximab (IFX), is highly effective in inducing and maintaining remission of patients with Inflammatory Bowel Diseases (IBD). However, a large portion of patients develop secondary loss of response mainly due to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f581ddc91be359b6bf222586126d4430
https://doi.org/10.1016/s0016-5085(15)32913-9
https://doi.org/10.1016/s0016-5085(15)32913-9